Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Lerda-Casaccia

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurology. Clinical Practice|November 11, 2024
Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple SclerosisSimon Hefner, Tiago Lerda Casaccia, Edda Hofstaetter, et al.
Scientific Reports|March 20, 2025
Financial burden of out of pocket nonpharmacological therapies in an Austrian multiple sclerosis cohortTiago Lerda Casaccia, Simon Hefner, Jonas Strauss, et al.
Medicina Clinica|March 4, 2026
Association of lifestyle and metabolic factors with clinical performance in multiple sclerosis: A cross-sectional studyTiago Lerda-Casaccia, Josef-Martin Mitterwallner, Wolfgang Hitzl, et al.
Brain : a Journal of Neurology|July 5, 2026
Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trialTobias Moser, Wolfgang Hitzl, Tiago Lerda-Casaccia, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurology. Clinical Practice|November 11, 2024
Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple SclerosisSimon Hefner, Tiago Lerda Casaccia, Edda Hofstaetter, et al.
Scientific Reports|March 20, 2025
Financial burden of out of pocket nonpharmacological therapies in an Austrian multiple sclerosis cohortTiago Lerda Casaccia, Simon Hefner, Jonas Strauss, et al.
Medicina Clinica|March 4, 2026
Association of lifestyle and metabolic factors with clinical performance in multiple sclerosis: A cross-sectional studyTiago Lerda-Casaccia, Josef-Martin Mitterwallner, Wolfgang Hitzl, et al.
Brain : a Journal of Neurology|July 5, 2026
Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trialTobias Moser, Wolfgang Hitzl, Tiago Lerda-Casaccia, et al.
Pageof 1